Bend Bioscience (Formerly CoreRx) Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
431
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
15
- Investments
-
4
Bend Bioscience (Formerly CoreRx) General Information
Description
Operator of a contract development manufacturing organization (CDMO intended to serve pharmaceutical and biotechnology companies. The company provides comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms, from pre-formulation work to final formulation development, enabling clients to maximize their investments, shorten development time and reduce overall costs.
Contact Information
Website
www.bendbioscience.comCorporate Office
- 14205 Myerlake Circle
- Clearwater, FL 33760
- United States
Corporate Office
- 14205 Myerlake Circle
- Clearwater, FL 33760
- United States
Bend Bioscience (Formerly CoreRx) Timeline
Bend Bioscience (Formerly CoreRx) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bend Bioscience (Formerly CoreRx) Comparisons
Industry
Financing
Details
Bend Bioscience (Formerly CoreRx) Competitors (24)
One of Bend Bioscience (Formerly CoreRx)’s 24 competitors is Sterling Pharma Solutions, a Private Equity-Backed company based in Cramlington, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sterling Pharma Solutions | Private Equity-Backed | Cramlington, United Kingdom | ||||
| Serán BioScience | Private Equity-Backed | Bend, OR | ||||
| Alcami | Private Equity-Backed | Wilmington, NC | ||||
| Recipharm | Private Equity-Backed | Stockholm, Sweden | ||||
| LGM Pharma | Private Equity-Backed | Boca Raton, FL |
Bend Bioscience (Formerly CoreRx) Patents
Bend Bioscience (Formerly CoreRx) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200253877-A1 | Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor | Inactive | 18-Oct-2018 | ||
| US-20190008779-A1 | Gemcabene compositions and methods of use thereof | Inactive | 11-May-2017 |
Bend Bioscience (Formerly CoreRx) Signals
Bend Bioscience (Formerly CoreRx) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bend Bioscience (Formerly CoreRx) Investments (4)
Bend Bioscience (Formerly CoreRx)’s most recent deal was a Buyout/LBO with Societal CDMO for . The deal was made on 28-Feb-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Societal CDMO | 28-Feb-2024 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Bend Bioscience (Acquired) | 11-Oct-2022 | Buyout/LBO | Drug Delivery | ||
| Nucleo Life Sciences | 24-May-2021 | Buyout/LBO | Drug Discovery | ||
| Production Joint Venture for TSX-002 ( CoreRx / TesoRx Pharma) | 28-Aug-2013 | Joint Venture | Drug Delivery |
Bend Bioscience (Formerly CoreRx) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bend Bioscience (Acquired) | Bend, OR | 1998 |
Bend Bioscience (Formerly CoreRx) FAQs
-
When was Bend Bioscience (Formerly CoreRx) founded?
Bend Bioscience (Formerly CoreRx) was founded in 2006.
-
Where is Bend Bioscience (Formerly CoreRx) headquartered?
Bend Bioscience (Formerly CoreRx) is headquartered in Clearwater, FL.
-
What is the size of Bend Bioscience (Formerly CoreRx)?
Bend Bioscience (Formerly CoreRx) has 431 total employees.
-
What industry is Bend Bioscience (Formerly CoreRx) in?
Bend Bioscience (Formerly CoreRx)’s primary industry is BPO/Outsource Services.
-
Is Bend Bioscience (Formerly CoreRx) a private or public company?
Bend Bioscience (Formerly CoreRx) is a Private company.
-
What is Bend Bioscience (Formerly CoreRx)’s current revenue?
The current revenue for Bend Bioscience (Formerly CoreRx) is .
-
How much funding has Bend Bioscience (Formerly CoreRx) raised over time?
Bend Bioscience (Formerly CoreRx) has raised $40.8M.
-
Who are Bend Bioscience (Formerly CoreRx)’s investors?
Juna Equity Partners, JVC Investment Partners, and QHP Capital have invested in Bend Bioscience (Formerly CoreRx).
-
Who are Bend Bioscience (Formerly CoreRx)’s competitors?
Sterling Pharma Solutions, Serán BioScience, Alcami, Recipharm, and LGM Pharma are some of the 24 competitors of Bend Bioscience (Formerly CoreRx).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process